Strategic Partnerships Accord Healthcare maintains active collaborations across regions, including recent partnerships with HIPRA and ImmunityBio, indicating a strong openness to co-development and distribution opportunities that can be leveraged to expand market access and accelerate product launches.

European Launch Engine With one of the most active launch programmes in Europe and operations spanning 85 countries, Accord demonstrates capability to rapidly introduce affordable medicines, suggesting opportunities to collaborate on timely launches, biosimilars, and access programs in new markets.

Biosimilar Growth Recent biosimilar launches such as Osvyrti and Jubereq position Accord in high-potential segments; sales teams can target hospitals and health systems seeking cost-effective biologics, while monitoring patent landscapes for new biosimilar opportunities.

Oncology Focus Accord’s deep heritage in oncology and partnerships in the UAE and beyond indicate continued demand for affordable cancer therapies, presenting upsell and value-based offerings to national health systems and patient access programs.

Digital and Compliance Readiness A tech stack featuring SAP, Oracle/JD Edwards, OneTrust, and monitoring tools signals mature governance and data capabilities, enabling data-driven account targeting, secure clinical/commercial data sharing, and streamlined procurement conversations with health systems.